Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
12 Jul 2022
Historique:
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 19 7 2022
Statut: epublish

Résumé

Nonsmall-cell lung cancer (NSCLC) is the most common type of lung cancer, with a dismal prognosis. NSCLC is a highly vascularized tumor, and chemotherapy is often hampered by the development of angiogenesis. Therefore, suppression of angiogenesis is considered a potential treatment approach. Tannic acid (TA), a natural polyphenol, has been demonstrated to have anticancer properties in a variety of cancers; however, its angiogenic properties have yet to be studied. Hence, in the current study, we investigated the antiproliferative and antiangiogenic effects of TA on NSCLC cells. The (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2

Identifiants

pubmed: 35847334
doi: 10.1021/acsomega.2c02727
pmc: PMC9281317
doi:

Types de publication

Journal Article

Langues

eng

Pagination

23939-23949

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

© 2022 The Authors. Published by American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Front Microbiol. 2012 Apr 23;3:130
pubmed: 22536197
Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1083-8
pubmed: 11588135
Semin Cancer Biol. 2015 Dec;35 Suppl:S224-S243
pubmed: 25600295
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Metab Brain Dis. 2020 Feb;35(2):283-293
pubmed: 31773434
Cancer Growth Metastasis. 2015 Jan 29;8:1-13
pubmed: 25674014
J Natl Cancer Inst. 1997 Jun 18;89(12):881-6
pubmed: 9196255
PLoS One. 2012;7(4):e35368
pubmed: 22523587
Biomolecules. 2019 Nov 22;9(12):
pubmed: 31766707
Cancer Lett. 2016 Nov 1;382(1):44-52
pubmed: 27569654
J Thorac Oncol. 2012 Mar;7(3):609-20
pubmed: 22307008
J Hepatol. 2007 Feb;46(2):222-9
pubmed: 17069924
Int J Nanomedicine. 2018 Feb 16;13:991-1007
pubmed: 29497293
Curr Oncol Rep. 2015 Jun;17(6):26
pubmed: 25947099
Acta Histochem. 2010;112(1):3-25
pubmed: 19162308
PLoS One. 2013 Aug 15;8(8):e71071
pubmed: 23967153
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Cancer Res. 2008 Mar 15;68(6):1843-50
pubmed: 18339865
J Colloid Interface Sci. 2019 Feb 1;535:133-148
pubmed: 30292104
Transl Lung Cancer Res. 2015 Oct;4(5):515-23
pubmed: 26629420
Brain Pathol. 1994 Jul;4(3):207-18
pubmed: 7524960
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Biochem Biophys Rep. 2019 Jan 25;17:197-207
pubmed: 30723809
Nature. 2011 May 19;473(7347):298-307
pubmed: 21593862
Front Mol Biosci. 2020 Apr 23;7:71
pubmed: 32391381
Sci Rep. 2020 Jul 21;10(1):12045
pubmed: 32694520
Anticancer Res. 2020 Jun;40(6):3209-3220
pubmed: 32487615
ACS Biomater Sci Eng. 2019 May 13;5(5):2343-2354
pubmed: 33405784
PLoS One. 2011;6(11):e27762
pubmed: 22114686
Mini Rev Med Chem. 2008 Oct;8(12):1179-87
pubmed: 18855732
Pharmaceutics. 2018 Aug 01;10(3):
pubmed: 30071698
Front Oncol. 2018 Jul 02;8:248
pubmed: 30013950
Clin Chest Med. 2011 Dec;32(4):605-44
pubmed: 22054876
Breast Cancer Res. 2003;5(3):140-6
pubmed: 12793895
Anticancer Agents Med Chem. 2016;16(6):781-9
pubmed: 26555610
Toxicol Appl Pharmacol. 2011 Mar 15;251(3):191-200
pubmed: 21194538
Tumour Biol. 2016 Feb;37(2):2137-43
pubmed: 26349913
J Ethnopharmacol. 2020 Oct 5;260:113039
pubmed: 32497675
Cancers (Basel). 2018 Mar 07;10(3):
pubmed: 29518944
Nat Med. 2003 Jun;9(6):669-76
pubmed: 12778165
Genes (Basel). 2019 Jul 26;10(8):
pubmed: 31357510
Food Funct. 2018 Nov 14;9(11):5547-5559
pubmed: 30259036
Cancer Res. 1997 Oct 15;57(20):4593-9
pubmed: 9377574
Fitoterapia. 2002 Dec;73(7-8):564-8
pubmed: 12490213
J Cell Mol Med. 2017 Apr;21(4):720-734
pubmed: 27862996
Front Oncol. 2021 May 28;11:655316
pubmed: 34123809
Biomed Res Int. 2014;2014:761264
pubmed: 24587990
Nat Rev Cancer. 2009 Apr;9(4):265-73
pubmed: 19262571
Int J Breast Cancer. 2013;2013:369609
pubmed: 24369505
Clin Cancer Res. 2003 Aug 1;9(8):3115-23
pubmed: 12912963
Asian Pac J Cancer Prev. 2019 Jan 25;20(1):199-206
pubmed: 30678432
Semin Oncol. 2014 Apr;41(2):235-51
pubmed: 24787295
Anticancer Drugs. 2012 Oct;23(9):979-90
pubmed: 22785358
Sci Rep. 2020 Jan 22;10(1):980
pubmed: 31969643
Crit Rev Food Sci Nutr. 1998 Aug;38(6):421-64
pubmed: 9759559
Biochem Pharmacol. 1985 Apr 1;34(7):905-9
pubmed: 2580535
Cell Signal. 2007 Oct;19(10):2003-12
pubmed: 17658244
J Clin Oncol. 2005 May 10;23(14):3243-56
pubmed: 15886312
Carcinogenesis. 2010 Mar;31(3):481-8
pubmed: 19969552

Auteurs

Elham Hatami (E)

Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
Department of Bioengineering, University of California, Los Angeles, California 90095, United States.

Prashanth K B Nagesh (PK)

Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
Laboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.

Mohammed Sikander (M)

Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.
South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.

Anupam Dhasmana (A)

Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.
South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.

Subhash C Chauhan (SC)

Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.
South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.

Meena Jaggi (M)

Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.
South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.

Murali M Yallapu (MM)

Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.
South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, Texas 78504, United States.

Classifications MeSH